Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |